P=N/A, N=36, Not yet recruiting, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology; Union Hospital, Tongji Medical College, Huazhong University of
P4, N=17, Recruiting, Institute of Hematology& Blood Disease Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College; Institute of Hematology&a | Not yet recruiting --> Recruiting
P=N/A, N=36, Active, not recruiting, Kyowa Kirin Co., Ltd. | Enrolling by invitation --> Active, not recruiting | Trial completion date: Jun 2024 --> Jun 2026
P2, N=43, Recruiting, Institute of Hematology & Blood Diseases Hospital, China | Trial completion date: Jun 2027 --> Dec 2025 | Trial primary completion date: Jan 2027 --> Dec 2024
5 months ago
Trial completion date • Trial primary completion date
Our aim is to determine differentially expressed genes (DEGs) related to Asparaginase, Daunorubicin, Prednisolone, and Vincristine resistance and identify potential inhibitors via docking...Following ADMET analysis, three drugs emerged as potential inhibitors: Flunarizine, Talniflumate, and Eltrombopag...This study promotes a further understanding of drug resistance in ALL, introducing novel genes for consideration in diagnostic screening. It also presents potential inhibitor candidates to tackle drug resistance through repurposing.